Tag: Competition

Displaying 81 - 100 of 2741 results.

Pages

The FTC is mailing checks to hospitals and clinics who overpaid for radiopharmaceuticals. The FTC settled a lawsuit against Cardinal Health Inc., in which the FTC alleged that Cardinal Health unlawfully monopolized the market for low-energy radiopharmaceuticals in 25 geographic areas throughout the...
In testimony presented to a U.S. House Judiciary Subcommittee, Acting Federal Trade Commission Chairman Maureen K. Ohlhausen described the FTC’s extensive work on the potential competitive effects of excessive occupational licensing through research, education, advocacy, and enforcement.
The Federal Trade Commission and Department of Justice today announced the release of antitrust guidance for businesses taking part in relief efforts and those involved in rebuilding communities affected by Hurricanes Harvey and Irma.
The Federal Trade Commission’s Economic Liberty Task Force announced today that it will hold its second roundtable in Washington, DC on Nov.
On November 7, 2017, the Federal Trade Commission’s Economic Liberty Task Force hosted a roundtable to examine empirical evidence on the effects of occupational licensure.
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced today that she has selected Ian R. Conner, a partner in the Antitrust & Competition group at the law firm of Kirkland & Ellis LLP, to be an Acting Deputy Director of the FTC’s Bureau of Competition, effective Sept. 18,...
The Hart Scott Rodino (HSR) Act and Rules require that parties to certain mergers and acquisitions submit premerger notification filings and wait before consummating the transaction. Parties must often balance the HSR filing requirement with a number of other regulatory requirements,...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business.
Mars, Incorporated has agreed to divest 12 veterinary clinics around the United States that provide specialty and emergency services to settle Federal Trade Commission charges that Mars’s $9.1 billion acquisition of pet care company VCA Inc. would violate federal antitrust laws.
Physicians’ practices vary widely, as do their effectiveness and reimbursement. Using a merger of six orthopaedic groups in southeastern Pennsylvania, we find that such groups can generate large, anti‐competitive price increases without any demonstrated increases in quality (...

Pages